GGrantIndex
Sort

16,300 grants matching fatty liver disease

Environmental chemical exposures during pregnancy and women's cardio-metabolic health

$420,773
Dana Dabelea · University Of Colorado Denver · R01 · FY2023 · ES

Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice

$420,765
Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2023 · DK

Collaborative Cross of the Microbiome and Metabolic Disease

$420,753
Federico E Rey · University Of Wisconsin-Madison · R01 · FY2016 · DK

Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis

$420,750
John Daniel Clarke · Washington State University · R01 · FY2023 · ES

Defining the roles of ACAD10/11 in hydroxy lipid catabolism and metabolic disease

$420,728
David J Pagliarini · Washington University · R01 · FY2024 · DK

Nuclear Repressors in Genomic Control of Healthful Obesity

$420,683
Grant D Barish · Northwestern University At Chicago · R01 · FY2024 · DK

Functional Analysis of MGAT Enzymes

$420,647
Robert V Farese · J. David Gladstone Institutes · R01 · FY2010 · DK

Mitochondrial Modulation of Endothelia Function

$420,594
John Francis Keaney · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · HL

Combining experiments of man and nature to target human insulin resistance

$420,525
Amit Majithia · University Of California, San Diego · R01 · FY2020 · DK

Therapeutic roles of hepatocyte exosomes in the liver

$420,510
David R Brigstock · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · AA

Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women

$420,482
Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Anti-inflammatory functions for non-transcriptional IRF3

$420,465
Saurabh Chattopadhyay · University Of Kentucky · R01 · FY2024 · AI

The Role of Phosphatidylinositides in Lipid Metabolism

$420,401
Marisa Wong Medina · University Of California, San Francisco · R01 · FY2021 · HL

Epidemiologic studies of maternal and early life metabolic risk

$420,344
Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Diabetes/obesity prevention in youth

$420,344
Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Lipids, Inflammation and Insulin Action

$420,213
Harvard University (Sch Of Public Hlth) · R01 · FY2005 · DK

An Obesity-Induced Kinase that Regulates Adipose Homeostasis and Metabolic Diseases

$420,175
James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK

An Obesity-Induced Kinase that Regulates Adipose Homeostasis and Metabolic Diseases

$420,175
James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK

An Obesity-Induced Kinase that Regulates Adipose Homeostasis and Metabolic Diseases

$420,175
James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK

An Obesity-Induced Kinase that Regulates Adipose Homeostasis and Metabolic Diseases

$420,175
James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK

Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk

$420,145
John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2023 · DK

Immunopathogenesis of Non-alcoholic Fatty Liver Disease

$420,135
Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · DK

The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer

$420,063
Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK

The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer

$420,063
Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK

Reactive Species in Vascular Disease: Mechanisms of Injury

$420,000
Harry Ischiropoulos · Children'S Hosp Of Philadelphia · R01 · FY2017 · HL